diethylstilbestrol has been researched along with raloxifene hydrochloride in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 4 (40.00) | 18.2507 |
| 2000's | 4 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodie, AM; Catt, KJ; Knecht, M | 1 |
| Bégin, D; Labrie, F; Luthy, IA | 1 |
| Logie, C; Nichols, M; Rientjes, JM; Stewart, AF | 1 |
| Bélanger, A; Caron, B; Cloutier, J; Dory, YL; Favre, A; Gauthier, S; Labrie, C; Labrie, F; Larouche, D; Leblanc, G; Mailhot, J; Martel, C; Mérand, Y; Ouellet, C; Schwerdtfeger, A; Simard, J | 1 |
| Gustafsson, J; Kuiper, GG; Kushner, PJ; Nilsson, S; Paech, K; Scanlan, TS; Webb, P | 1 |
| Funder, JW; Logie, C; Myles, K; Nichols, M; Stewart, AF | 1 |
| Grümmer, R; Heikaus, S; Traub, O; Winterhager, E | 1 |
| Hayes, DF | 1 |
| Flaig, R; Greschik, H; Moras, D; Renaud, JP | 1 |
| Nose, T; Shimohigashi, Y; Tokunaga, T | 1 |
10 other study(ies) available for diethylstilbestrol and raloxifene hydrochloride
| Article | Year |
|---|---|
Aromatase inhibitors prevent granulosa cell differentiation: an obligatory role for estrogens in luteinizing hormone receptor expression.
Topics: Androstenedione; Animals; Aromatase Inhibitors; Cell Differentiation; Cells, Cultured; Cyclic AMP; Delayed-Action Preparations; Diethylstilbestrol; Estradiol; Estrogens; Female; Flutamide; Follicle Stimulating Hormone; Granulosa Cells; Oxidoreductases; Piperidines; Raloxifene Hydrochloride; Rats; Receptors, Cell Surface; Receptors, LH; Time Factors | 1985 |
Mediation by the androgen receptor of the stimulatory and antiandrogenic actions of 17 beta-estradiol on the growth of androgen-sensitive Shionogi mammary carcinoma cells in culture.
Topics: Androgen Antagonists; Animals; Cell Division; Cell Line; Diethylstilbestrol; Dihydrotestosterone; Estradiol; Estrogen Antagonists; Kinetics; Male; Mammary Neoplasms, Experimental; Mice; Piperidines; Raloxifene Hydrochloride; Receptors, Androgen; Testosterone | 1988 |
FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; Diethylstilbestrol; DNA Nucleotidyltransferases; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Hexestrol; HSP90 Heat-Shock Proteins; Humans; Ligands; Molecular Sequence Data; Nafoxidine; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Time Factors; Yeasts | 1997 |
(S)-(+)-4-[7-(2,2-dimethyl-1-oxopropoxy)-4-methyl-2-[4-[2-(1-piperidinyl)-ethoxy]phenyl]-2H-1-benzopyran-3-yl]-phenyl 2,2-dimethylpropanoate (EM-800): a highly potent, specific, and orally active nonsteroidal antiestrogen.
Topics: Administration, Oral; Animals; Benzopyrans; Binding, Competitive; Breast Neoplasms; Cytosol; Diethylstilbestrol; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Molecular Structure; Ovariectomy; Piperidines; Propionates; Raloxifene Hydrochloride; Receptors, Estrogen; Stereoisomerism; Structure-Activity Relationship; Uterus | 1997 |
Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.
Topics: Animals; Breast Neoplasms; Cell Line; Diethylstilbestrol; Enhancer Elements, Genetic; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogen Receptor beta; Estrogens; Female; HeLa Cells; Humans; Ligands; Piperidines; Polyunsaturated Alkamides; Raloxifene Hydrochloride; Rats; Receptors, Estrogen; Tamoxifen; Transcription Factor AP-1; Transcriptional Activation; Transfection; Tumor Cells, Cultured; Uterus | 1997 |
Positive and negative discrimination of estrogen receptor agonists and antagonists using site-specific DNA recombinase fusion proteins.
Topics: Diethylstilbestrol; Dimerization; DNA Nucleotidyltransferases; Estradiol; Estrogen Antagonists; Fulvestrant; Hexestrol; Humans; Mutation; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen | 1998 |
Responsiveness of endometrial genes Connexin26, Connexin43, C3 and clusterin to primary estrogen, selective estrogen receptor modulators, phyto- and xenoestrogens.
Topics: Animals; Clusterin; Complement C3; Connexin 26; Connexin 43; Connexins; Diethylstilbestrol; Endometrium; Estrogens; Estrogens, Non-Steroidal; Female; Gene Expression Regulation; Glycoproteins; Isoflavones; Molecular Chaperones; Phytoestrogens; Plant Preparations; Polychlorinated Biphenyls; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Selective Estrogen Receptor Modulators; Tamoxifen | 2002 |
Playing the old piano: another tune for endocrine therapy?
Topics: Antineoplastic Agents, Hormonal; Breast Neoplasms; Cell Line, Tumor; Clinical Trials as Topic; Diethylstilbestrol; Disease Progression; Drug Administration Schedule; Estrogen Receptor Modulators; Female; Humans; Male; Neoplasms, Hormone-Dependent; Ovariectomy; Raloxifene Hydrochloride; Receptors, Estrogen; Selective Estrogen Receptor Modulators; Tamoxifen; Time Factors; Treatment Outcome | 2003 |
Structural basis for the deactivation of the estrogen-related receptor gamma by diethylstilbestrol or 4-hydroxytamoxifen and determinants of selectivity.
Topics: Animals; Binding Sites; Crystallization; Diethylstilbestrol; Dimerization; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens, Non-Steroidal; Mice; Models, Molecular; Peptide Fragments; Protein Conformation; Protein Structure, Secondary; Raloxifene Hydrochloride; Receptors, Cytoplasmic and Nuclear; Receptors, Estrogen; Recombinant Proteins; Tamoxifen | 2004 |
Exploration of endocrine-disrupting chemicals on estrogen receptor alpha by the agonist/antagonist differential-docking screening (AADS) method: 4-(1-adamantyl)phenol as a potent endocrine disruptor candidate.
Topics: Adamantane; Diethylstilbestrol; Endocrine Disruptors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Ligands; Luciferases; Models, Molecular; Phenols; Raloxifene Hydrochloride; Selective Estrogen Receptor Modulators; Structure-Activity Relationship; Tamoxifen | 2009 |